Summary
This is a NEW cochlear implant coverage policy effective October 1, 2026, establishing medical necessity criteria for cochlear implant implantation and replacement across four scenarios: bilateral hearing loss (standard implants or hybrid systems), and single-sided deafness. The policy defines specific audiometric thresholds, hearing aid trial requirements, contraindications, and documentation requirements that billing and clinical teams must use to determine coverage eligibility.
Get alerts when payers change rules like this one
We check Regence BlueShield and other payers every day and email you when a change matches your specialty and state.
Get Regence BlueShield alertsPolicy Monitoring is free. No card required.
What to do
Action · 10 steps
01REQUIREMENTS:
Before October 1, 2026: Providers and billing team must review and implement this new policy:
1.
02Clinical Documentation Team: Update patient intake forms and pre-operative checklists to capture all required documentation per Criteria I-IV, including: (a) Audiometric thresholds (pure-tone averages at 500Hz, 1000Hz, 2000Hz, 4000Hz as applicable); (b) Hearing aid trial results with specific sentence recognition scores (≤50% for adults, ≤30% for children on open-set tests); (c) Contraindication screening (acoustic nerve lesions, middle ear infections, tympanic perforation, cochlear development absence, willingness for rehabilitation); (d) FDA approval verification of device; (e) Progressive hearing loss documentation if applicable (for Criterion I.A.1.b); (f) Hybrid system specific thresholds if applicable (Criterion II.D detailed frequency-specific requirements).
032. Billing Team: Create internal policy reference guide distinguishing four coverage pathways: Pathway 1 (Criterion I - bilateral standard implants, any age), Pathway 2 (Criterion II - bilateral hybrid systems, age 18+ only), Pathway 3 (Criterion III - single-sided deafness, age 5+ only), Pathway IV (implant replacement for non-functional or inadequately responsive devices).
04Train team on specific exclusions (non-medically necessary per Criterion V if any Criterion I-III requirement unmet; Criterion VI for replacements that don't meet functional criteria).
053. Prior Authorization Process: Implement pre-authorization requirement for all cochlear implant cases to verify the applicable criterion pathway is met before surgery authorization.
06Ensure documentation package includes audiograms, hearing aid trial reports, contraindication screening, and device FDA approval status.
074. Providers: Ensure informed consent discussions document patient understanding that repeat hearing tests/hearing aid trials are not required if patient previously met Criteria I.A and II.A (per policy note: unlikely natural hearing will improve).
08FAILURE TO IMPLEMENT: Claims submitted without appropriate medical necessity documentation per the applicable criterion (I, II, III, or IV) will be denied as not meeting policy requirements.
09Hybrid system implants billed to members without age ≥18 verification will be denied.
10Single-sided deafness implants for patients under age 5 will be denied.
Original notice
Cochlear Implants
beonbrand.getbynder.com · Always check the source before changing claims.